Dark biotechnology, often referred to as "black biotechnology," encompasses the application of biotechnological processes to develop products or technologies with potentially harmful or controversial implications. Unlike its counterparts in white and red biotechnology, which focus on medical and industrial applications, dark biotechnology delves into areas that raise ethical concerns. This field includes activities such as bio-warfare research, bioterrorism, and the creation of biological weapons. The manipulation of living organisms for destructive purposes has sparked debates about the ethical boundaries and the need for stringent regulations to prevent the misuse of scientific advancements. The ethical considerations surrounding dark biotechnology highlight the importance of responsible research practices and global cooperation to mitigate the potential risks associated with these controversial applications.
Title : Renewed novel biotech ideas, with bioreactor bioengineering economic impact
Murray Moo Young, University of Waterloo, Canada
Title : Osmotic lysis–driven Extracellular Vesicle (EV) engineering
Limongi Tania, University of Turin, Italy
Title : Steps and strides: Cross-species insights into movement and injury
Babak Faramarzi, Western University of Health Sciences, United States
Title : Eliminating implant failure in humans with nano chemistry: 45,000 cases and counting
Thomas J Webster, Brown University, United States
Title : Scientist’s computational lawyer
Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain
Title : Evaluating cell compatibility and subcutaneous host response of silk fibroin–chitosan plug composites as potential resorbable implants
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico